Littérature scientifique sur le sujet « Class III β-tubulin »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Sommaire
Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Class III β-tubulin ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Articles de revues sur le sujet "Class III β-tubulin"
Jouhilahti, Eeva-Mari, Sirkku Peltonen et Juha Peltonen. « Class III β-Tubulin Is a Component of the Mitotic Spindle in Multiple Cell Types ». Journal of Histochemistry & ; Cytochemistry 56, no 12 (2 septembre 2008) : 1113–19. http://dx.doi.org/10.1369/jhc.2008.952002.
Texte intégralReader, Jocelyn, Amy K. Harper, Teklu Legesse, Paul N. Staats, Olga Goloubeva, Gautam G. Rao, Amy Fulton et Dana M. Roque. « EP4 and Class III β-Tubulin Expression in Uterine Smooth Muscle Tumors : Implications for Prognosis and Treatment ». Cancers 11, no 10 (18 octobre 2019) : 1590. http://dx.doi.org/10.3390/cancers11101590.
Texte intégralLaferrière, Nicole B., et D. L. Brown. « Effects of taxol on the polymerization and posttranslational modification of class III β-tubulin in P19 embryonal carcinoma cells ». Biochemistry and Cell Biology 73, no 9-10 (1 septembre 1995) : 687–94. http://dx.doi.org/10.1139/o95-076.
Texte intégralLinhartová, I., P. Dráber, E. Dráberová et V. Viklický. « Immunological discrimination of β-tubulin isoforms in developing mouse brain. Post-translational modification of non-class-III β-tubulins ». Biochemical Journal 288, no 3 (15 décembre 1992) : 919–24. http://dx.doi.org/10.1042/bj2880919.
Texte intégralGuo, Huiqin, Yu Zhao, Jiangyang Lu et Zejian Li. « ERCC1, class III β-tubulin, p53, and RRM1-tailored selection of personalized chemotherapy for stage IV NSCLC patients : A prospective study. » Journal of Clinical Oncology 30, no 15_suppl (20 mai 2012) : e18087-e18087. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e18087.
Texte intégralZhang, Shucai, Qi Li, Quan Zhang, Jinghui Wang, Haiqing Zhang, Zongde Zhang, Qunhui Wang, Xinjie Yang, Yanfei Gu et Hui Zhang. « Expression of ERCC1 and Class III β-Tubulin in Resected Non-Small Cell Lung Cancer and its Correlation with Platinum-Based Adjuvant Chemotherapy ». International Journal of Biological Markers 25, no 3 (juillet 2010) : 141–49. http://dx.doi.org/10.1177/172460081002500304.
Texte intégralMariani, Marisa, Roshan Karki, Manuela Spennato, Deep Pandya, Shiquan He, Mirko Andreoli, Paul Fiedler et Cristiano Ferlini. « Class III β-tubulin in normal and cancer tissues ». Gene 563, no 2 (juin 2015) : 109–14. http://dx.doi.org/10.1016/j.gene.2015.03.061.
Texte intégralKatsetos, Christos D., Mary M. Herman et Sverre J. Mörk. « Class III β-tubulin in human development and cancer ». Cell Motility and the Cytoskeleton 55, no 2 (24 avril 2003) : 77–96. http://dx.doi.org/10.1002/cm.10116.
Texte intégralAlfano, Alan, Jin Xu, Xi Yang, Dhanraj Deshmukh et Yun Qiu. « SRC Kinase-Mediated Tyrosine Phosphorylation of TUBB3 Regulates Its Stability and Mitotic Spindle Dynamics in Prostate Cancer Cells ». Pharmaceutics 14, no 5 (25 avril 2022) : 932. http://dx.doi.org/10.3390/pharmaceutics14050932.
Texte intégralAlfano, Alan, Jin Xu, Xi Yang, Dhanraj Deshmukh et Yun Qiu. « SRC Kinase-Mediated Tyrosine Phosphorylation of TUBB3 Regulates Its Stability and Mitotic Spindle Dynamics in Prostate Cancer Cells ». Pharmaceutics 14, no 5 (25 avril 2022) : 932. http://dx.doi.org/10.3390/pharmaceutics14050932.
Texte intégralThèses sur le sujet "Class III β-tubulin"
Ploussard, Guillaume. « Biomarqueurs émergents dans le cancer de prostate : à propos de la β-tubuline de classe III et du score urinaire PCA3 ». Phd thesis, Université Paris-Est, 2011. http://tel.archives-ouvertes.fr/tel-00920469.
Texte intégralPEDICA, Federica. « Characterization of neoplastic and non-neoplastic microenvironment in liver, lung and bone marrow through the study of class III β-tubulin ». Doctoral thesis, 2016. http://hdl.handle.net/11562/938311.
Texte intégralThe following PhD thesis on Human Oncological Pathology and Stem Cell is focused on class III beta-tubulin (tubb3) that has been mainly investigated in oncological context for epithelial tumors as a marker of resistance to taxane and aggressiveness. Recently it has also been described as marker for pericytes, Recentemente è stata poi descritta come marker dei pericytes, which are cells indicating the maturity of vessels but have also contractility properties and morphologically recalls myofibroblasts. The presence of tubb3 in rare cases of hepatocellular carcinoma, differently compared to other carcinomas e the peculiar positivity in newly formed tumoral vessels, has suggested the possible wide potentiality of this marker compared to what has already been described in literature. For this reason we have decided to develop 3 projects in parallel on different diseases, both non-neoplastic (idiopathic pulmonary fibrosis) and neoplastic (hepatocellular carcinoma and primary myelofibrosis) conditions, that are in a way accumunated by the presence of a spindle population of cells resembling myofibroblasts. In pulmonary fibrosis, tubb3 identify the myofibroblasts forming fibroblastic foci, that are a pathognomonic lesion of the disease. This study has produced an original article that has been submitted. In Hepatocellular carcinoma, tubb3 is found only rarely in neoplastic cells, often at the front of edge of the tumor and in 1/3 of cases in peritumoral and intratumoral vessels. The peculiarity of these results has driven the idea of another study on dynamic 3D-cultures with Bioreactor, to investigate how tumoral vessels behave in dynamic cultures also when they are subjected to drug, such as Sorafenib. This study is on-going with the group of Tumor Microenvironment of ’Ospedale San Raffaele in Milano, where the Bioreactor is available. Concerning primary myelofibrosis, it was the name of the disease that suggested us to investigate this process with tubb3. Thank to the intial encouraging results, we have initiated a collaboration with the the Department of Haematology of Policlinico GB Rossi in Verona to understand id the patients that present a tubb3 positive population in the context of bone marrow biopsy have a different type of disease compared to other myelofibrosis and if this heterogeneity has some relation to mutational status.
Actes de conférences sur le sujet "Class III β-tubulin"
Mariani, Marisa, Marta De Donato, Lella Petrella, Enrica Martinelli, Gabriella Ferrandina, Gian Franco Zannoni, Giovanni Scambia, Shohreh Shahabi et Cristiano Ferlini. « Abstract 4055 : Class III β-tubulin and the cytoskeletal gateway of drug resistance in ovarian cancer ». Dans Proceedings : AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011 ; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-4055.
Texte intégralRoque, Dana M., Danielle Meir-Levi, Gautam G. Rao, Paul Staats, Amy Fulton et Jocelyn Reader. « Abstract 1179 : EP4 receptor antagonism in paclitaxel-resistant ovarian clear cell carcinomas that overexpress class III β-tubulin ». Dans Proceedings : AACR Annual Meeting 2017 ; April 1-5, 2017 ; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-1179.
Texte intégralMoon, Yongwha, Ja Seung Koo, Hyunju Han, Byeong-Woo Park, Seung Il Kim, Seho Park, Hyun Cheol Chung, Joo-Hang Kim et Joo Hyuk Sohn. « Abstract C10 : Class III β -tubulin predicts pathological response to neoadjuvant docetaxel-based chemotherapy in breast cancer patients. » Dans Abstracts : AACR-NCI-EORTC International Conference : Molecular Targets and Cancer Therapeutics--Nov 12-16, 2011 ; San Francisco, CA. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1535-7163.targ-11-c10.
Texte intégralMariani, Marisa, Gian Franco Zannoni, Stefano Sioletic, Steven Sieber, Candice Martino, Enrica Martinelli, Claudio Coco, Giovanni Scambia, Shohreh Shahabi et Cristiano Ferlini. « Abstract 4522 : Androgen receptor is a main driver of aggressiveness in colorectal cancer through the class III β-tubulin pathway ». Dans Proceedings : AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012 ; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-4522.
Texte intégralSumitomo, Ryota, Tatsuya Hirai, Hiyoaki Murakami, Yosuke Otake et Cheng-long Huang. « Abstract 4010 : Adjuvant chemotherapy based on the intratumoral expressions of class III β tubulin and thymidylate synthase improved disease-free survival in patients with resected locally advanced non-small cell lung cancer ». Dans Proceedings : AACR Annual Meeting 2019 ; March 29-April 3, 2019 ; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-4010.
Texte intégralFilho, Everton Chaves Correia, et Lia Camurça Costa. « RESISTÊNCIA DE HELMINTOS AOS BENZIMIDAZÓLICOS : UMAREVISÃO DE LITERATURA. » Dans II Congresso Brasileiro de Parasitologia Humana On-line. Revista Multidisciplinar em Saúde, 2022. http://dx.doi.org/10.51161/conbrapah/32.
Texte intégral